ClinicalTrials.govpublic full text
Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
tumors
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 28436 · SHA-256 17c3746fc8cd5ac2
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.